Drug intelligence / Profile preview

silver sulfadiazine + sodium hyaluronate

Development stage
Unknown
Lead developer
Verisfield
Modality
Small Molecules
Administration
Topical
01

Overview

Hy-Sil is a topical combination cream containing silver sulfadiazine (1% w/w) and sodium hyaluronate (0.2% w/w). Developed by Verisfield, it is indicated for the prevention and treatment of skin lesions, including wounds, varicose ulcers, and burns. Silver sulfadiazine acts as a broad-spectrum topical antimicrobial agent, preventing and treating bacterial infections in the wound bed. Sodium hyaluronate, a naturally occurring polysaccharide of the extracellular matrix, maintains a moist wound environment, promoting cellular migration, tissue regeneration, and re-epithelialization. Together, these components facilitate rapid wound healing while protecting against secondary bacterial contamination.

Brand names
Hy-Sil
Other names
silver sulfadiazine and sodium hyaluronatesilver sulfadiazine + sodium hyaluronatesodium hyaluronate + silver sulfadiazine
02

Targets

DHPS (Dihydropteroate synthase)CD44 (CD44 antigen)HMMR

Beyond the preview

Go deeper on silver sulfadiazine + sodium hyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silver sulfadiazine + sodium hyaluronate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call